Training in Neurotherapeutics Discovery and Development for Academic Scientists

为学术科学家提供神经治疗药物发现和开发培训

• 批准号: 8431353
• 负责人: MARCIE A GLICKSMAN
• 金额: $ 25.75万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-03-01 至 2017-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8431353
• 关键词: ADME Study; Academia; Achievement; Applications Grants; Area; Biological Assay; Biological Markers; Brain; Critiques; Data; Databases; Development; Development Plans; Disease; Drug Formulations; Elements; Faculty; Funding; Future; Goals; Grant; Individual; Industry; Intellectual Property; Journals; Knowledge; Lead; Learning; Medicine; Mentors; Mentorship; Participant; Peer Review; Pharmaceutical Chemistry; Postdoctoral Fellow; Process; Publishing; Quality of life; Research; Research Personnel; Scientist; Series; Specialist; Students; Time; Training; Training Programs; United States National Institutes of Health; Vision; Work; Writing; animal efficacy; base; cohort; design; disability; drug development; drug discovery; efficacy testing; experience; follow-up; improved; instructor; interest; knowledge base; lecturer; lectures; member; nervous system disorder; responsible research conduct; safety testing; skills; success; teacher

DESCRIPTION (provided by applicant): This project will develop and implement a training program in neurotherapeutics discovery and development for faculty members and advanced postdoctoral fellows, centered around a 3-day short course that will provide the trainees with the various knowledge elements required to discover and advance a neurotherapeutic agent to IND. Following the short course, the training program will continue for a two-year period in which students will have individualized mentoring and assessment. The training, which is designed to be applicable to diverse diseases of the nervous system, will equip students with a broad understanding of the various component steps in the neurotherapeutics drug discovery and development process. Students will learn how to identify a good drug discovery target; how to construct an assay; the elements of medicinal chemistry; how to conduct animal efficacy testing; the principles of ADME studies, safety testing, and formulation; the principles of experimental medicine and biomarkers; the steps required to prepare an IND document and the principles for interacting with the FDA; the principles of intellectual property as they relate to neurotherapeutics discovery and development; and how to seek funding for academic drug discovery research. They will also receive training in responsible conduct of research. Students will be equipped with the skills to develop and coordinate an entire drug discovery and development effort, and to work collaboratively with experts in each of the component areas. The training will combine didactic lectures with active engagement activities in which the students will be challenged to utilize the lecture material to work through their own drug discovery project plan with the guidance of the area experts. The 3-day short course (followed by two-years of mentorship and assessment) will be offered annually, a total of five times.

描述（由申请人提供）： 该项目将为教职员工和高级博士后研究员开发和实施神经治疗学发现和开发的培训计划，围绕为期3天的短期课程，为学员提供发现和推进神经治疗剂到IND所需的各种知识要素。培训方案将持续两年，学生将得到个性化的指导和评估。该培训旨在适用于神经系统的各种疾病，将使学生对神经治疗药物发现和开发过程中的各个组成步骤有广泛的了解。学生将学习如何确定一个良好的药物发现目标;如何构建一个分析;药物化学的元素;如何进行动物疗效测试; ADME研究，安全性测试和配方的原则;实验医学和生物标志物的原则;准备IND文件所需的步骤和与FDA互动的原则;知识产权的原则，因为它们涉及到神经疗法的发现和发展;以及如何寻求学术药物发现研究的资金。他们还将接受负责任地开展研究的培训。学生将具备开发和协调整个药物发现和开发工作的技能，并与每个组成领域的专家合作。该培训将结合联合收割机教学讲座与积极参与活动，其中学生将面临挑战，利用讲座材料，通过自己的药物发现项目计划的工作与地区专家的指导。为期3天的短期课程（随后是两年的指导和评估）将每年提供，共五次。